glp 1 agonist abbreviation GLP-1 and Anesthesia: Considerations and Cautions for CRNAs The dual glucose-dependent insulinotropic polypeptide

Results of randomized trials Six large randomized trials and a post hoc analysis 1521 have investigated the safety and efficacy of GLP-1 receptor agonists in patients with type 2 diabetes who also either had known cardiovascular disease or were at high risk of it, using a composite of major adverse cardiovascular events (myocardial infarction, stroke, or death from cardiovascular causes) as the primary end point (Table 2)

If you are researching retatrutide dosing , follow the same conservative approach as tirzepatide until official guidelines are published

This isnt the full list of side effects for phentermine/topiramate ER

pH-temperature responsive hydrogel-mediated delivery of exendin-4 encapsulated chitosan nanospheres for sustained therapeutic efficacy in type 2 diabetes mellitus